Bulletin
Investor Alert

Syros Pharmaceuticals Inc.

NAS: SYRS

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Syros Pharmaceuticals Inc.

After Hours

SYRS
/zigman2/quotes/201168308/composite

$

5.09

Change

-0.02 -0.39%

Volume

Volume 3,633

Jan 31, 2023, 7:32 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/201168308/composite

Today's close

$ 4.85

$ 5.11

Change

+0.26 +5.36%

Day low

Day high

$4.84

$5.39

Open
Open: 4.84

52 week low

52 week high

$3.02

$21.90

Open

Market cap

$98.10M

Average volume

120,319

P/E ratio

N/A

Rev. per Employee

$189,000

EPS

-16.39

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/syrs

MarketWatch News on SYRS

  1. Syros Pharmaceuticals stock price target cut to $10 from $14 at Alliance Global

    4:59 a.m. May 17, 2022

    - Tomi Kilgore

  2. Syros Pharmaceuticals stock price target cut to $8 from $10 at Wedbush

    7:18 a.m. Dec. 7, 2020

    - Tomi Kilgore

  3. Syros Pharmaceuticals downgraded to neutral from outperform at Wedbush

    8:27 a.m. Jan. 17, 2020

    - Tomi Kilgore

  5. Syros Pharmaceuticals started at outperform with $18 stock price target at Wedbush Securities

    6:24 a.m. July 25, 2016

    - Tomi Kilgore

  6. Syros Pharmaceuticals sets IPO price expectations

    6:44 a.m. June 20, 2016

    - Tomi Kilgore

  7. Syros Pharmaceuticalsto offer 4 mln shares in its IPO

    6:32 a.m. June 20, 2016

    - Tomi Kilgore

  8. Syros Pharmaceuticals expects IPO price of between $14 and $16 a share

    6:31 a.m. June 20, 2016

    - Tomi Kilgore

Analyst Ratings

/news/nonmarketwatch/company/us/syrs

Other News on SYRS

  3. 10-Q: SYROS PHARMACEUTICALS, INC.

    7:20 a.m. Nov. 14, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  4. Syros Pharmaceuticals Q3 2022 Earnings Preview

    12:20 p.m. Nov. 11, 2022

    - Seeking Alpha

  5. Notable earnings before Monday's open

    9:23 a.m. Nov. 11, 2022

    - Seeking Alpha

  11. Syros Pharmaceuticals: A Major Vote Of Confidence From Insiders

    5:45 a.m. Sept. 20, 2022

    - Seeking Alpha

  12. AVCT, MSC and VTAQ among mid-day movers

    12:06 p.m. Sept. 19, 2022

    - Seeking Alpha

  20. 10-Q: SYROS PHARMACEUTICALS, INC.

    6:28 a.m. Aug. 9, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  21. Loading more headlines...
/news/pressrelease/company/us/syrs

Press Releases on SYRS

  2. Syros Announces Clinical Updates and 2023 Strategic Priorities

    7:00 a.m. Jan. 9, 2023

    - BusinessWire - BZX

  3. Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    4:05 p.m. Dec. 23, 2022

    - BusinessWire - BZX

  11. Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    3:30 p.m. Nov. 4, 2022

    - BusinessWire - BZX

  13. Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    3:01 p.m. Oct. 5, 2022

    - BusinessWire - BZX

  18. Syros and Tyme Technologies Announce Stockholder Approval of Merger

    3:01 p.m. Sept. 15, 2022

    - BusinessWire - BZX

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.